Augmenting Vacuolar H<sup>+</sup>-ATPase Function Prevents Cardiomyocytes from Lipid-Overload Induced Dysfunction

The diabetic heart is characterized by a shift in substrate utilization from glucose to lipids, which may ultimately lead to contractile dysfunction. This substrate shift is facilitated by increased translocation of lipid transporter CD36 (SR-B2) from endosomes to the sarcolemma resulting in increas...

Full description

Bibliographic Details
Main Authors: Shujin Wang, Li-Yen Wong, Dietbert Neumann, Yilin Liu, Aomin Sun, Gudrun Antoons, Agnieszka Strzelecka, Jan F.C. Glatz, Miranda Nabben, Joost J.F.P. Luiken
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/4/1520
id doaj-058274f6313e4bea9e05c70e0de16bf4
record_format Article
spelling doaj-058274f6313e4bea9e05c70e0de16bf42020-11-25T01:40:48ZengMDPI AGInternational Journal of Molecular Sciences1422-00672020-02-01214152010.3390/ijms21041520ijms21041520Augmenting Vacuolar H<sup>+</sup>-ATPase Function Prevents Cardiomyocytes from Lipid-Overload Induced DysfunctionShujin Wang0Li-Yen Wong1Dietbert Neumann2Yilin Liu3Aomin Sun4Gudrun Antoons5Agnieszka Strzelecka6Jan F.C. Glatz7Miranda Nabben8Joost J.F.P. Luiken9Department of Genetics &amp; Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200-MD Maastricht, The NetherlandsDepartment of Genetics &amp; Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200-MD Maastricht, The NetherlandsDepartments of Pathology, CARIM School for Cardiovascular Diseases, Maastricht University, 6200-MD Maastricht, The NetherlandsDepartment of Genetics &amp; Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200-MD Maastricht, The NetherlandsDepartment of Genetics &amp; Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200-MD Maastricht, The NetherlandsDepartments of Physiology, CARIM School for Cardiovascular Diseases, Maastricht University, 6200-MD Maastricht, The NetherlandsDepartment of Genetics &amp; Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200-MD Maastricht, The NetherlandsDepartment of Genetics &amp; Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200-MD Maastricht, The NetherlandsDepartment of Genetics &amp; Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200-MD Maastricht, The NetherlandsDepartment of Genetics &amp; Cell Biology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200-MD Maastricht, The NetherlandsThe diabetic heart is characterized by a shift in substrate utilization from glucose to lipids, which may ultimately lead to contractile dysfunction. This substrate shift is facilitated by increased translocation of lipid transporter CD36 (SR-B2) from endosomes to the sarcolemma resulting in increased lipid uptake. We previously showed that endosomal retention of CD36 is dependent on the proper functioning of vacuolar H<sup>+</sup>-ATPase (v-ATPase). Excess lipids trigger CD36 translocation through inhibition of v-ATPase function. Conversely, in yeast, glucose availability is known to enhance v-ATPase function, allowing us to hypothesize that glucose availability, via v-ATPase, may internalize CD36 and restore contractile function in lipid-overloaded cardiomyocytes. Increased glucose availability was achieved through (a) high glucose (25 mM) addition to the culture medium or (b) adenoviral overexpression of protein kinase-D1 (a kinase mediating GLUT4 translocation). In HL-1 cardiomyocytes, adult rat and human cardiomyocytes cultured under high-lipid conditions, each treatment stimulated v-ATPase re-assembly, endosomal acidification, endosomal CD36 retention and prevented myocellular lipid accumulation. Additionally, these treatments preserved insulin-stimulated GLUT4 translocation and glucose uptake as well as contractile force. The present findings reveal v-ATPase functions as a key regulator of cardiomyocyte substrate preference and as a novel potential treatment approach for the diabetic heart.https://www.mdpi.com/1422-0067/21/4/1520vacuolar h<sup>+</sup>-atpaselipid accumulationinsulin resistancecontractile functiondiabetic heart
collection DOAJ
language English
format Article
sources DOAJ
author Shujin Wang
Li-Yen Wong
Dietbert Neumann
Yilin Liu
Aomin Sun
Gudrun Antoons
Agnieszka Strzelecka
Jan F.C. Glatz
Miranda Nabben
Joost J.F.P. Luiken
spellingShingle Shujin Wang
Li-Yen Wong
Dietbert Neumann
Yilin Liu
Aomin Sun
Gudrun Antoons
Agnieszka Strzelecka
Jan F.C. Glatz
Miranda Nabben
Joost J.F.P. Luiken
Augmenting Vacuolar H<sup>+</sup>-ATPase Function Prevents Cardiomyocytes from Lipid-Overload Induced Dysfunction
International Journal of Molecular Sciences
vacuolar h<sup>+</sup>-atpase
lipid accumulation
insulin resistance
contractile function
diabetic heart
author_facet Shujin Wang
Li-Yen Wong
Dietbert Neumann
Yilin Liu
Aomin Sun
Gudrun Antoons
Agnieszka Strzelecka
Jan F.C. Glatz
Miranda Nabben
Joost J.F.P. Luiken
author_sort Shujin Wang
title Augmenting Vacuolar H<sup>+</sup>-ATPase Function Prevents Cardiomyocytes from Lipid-Overload Induced Dysfunction
title_short Augmenting Vacuolar H<sup>+</sup>-ATPase Function Prevents Cardiomyocytes from Lipid-Overload Induced Dysfunction
title_full Augmenting Vacuolar H<sup>+</sup>-ATPase Function Prevents Cardiomyocytes from Lipid-Overload Induced Dysfunction
title_fullStr Augmenting Vacuolar H<sup>+</sup>-ATPase Function Prevents Cardiomyocytes from Lipid-Overload Induced Dysfunction
title_full_unstemmed Augmenting Vacuolar H<sup>+</sup>-ATPase Function Prevents Cardiomyocytes from Lipid-Overload Induced Dysfunction
title_sort augmenting vacuolar h<sup>+</sup>-atpase function prevents cardiomyocytes from lipid-overload induced dysfunction
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1422-0067
publishDate 2020-02-01
description The diabetic heart is characterized by a shift in substrate utilization from glucose to lipids, which may ultimately lead to contractile dysfunction. This substrate shift is facilitated by increased translocation of lipid transporter CD36 (SR-B2) from endosomes to the sarcolemma resulting in increased lipid uptake. We previously showed that endosomal retention of CD36 is dependent on the proper functioning of vacuolar H<sup>+</sup>-ATPase (v-ATPase). Excess lipids trigger CD36 translocation through inhibition of v-ATPase function. Conversely, in yeast, glucose availability is known to enhance v-ATPase function, allowing us to hypothesize that glucose availability, via v-ATPase, may internalize CD36 and restore contractile function in lipid-overloaded cardiomyocytes. Increased glucose availability was achieved through (a) high glucose (25 mM) addition to the culture medium or (b) adenoviral overexpression of protein kinase-D1 (a kinase mediating GLUT4 translocation). In HL-1 cardiomyocytes, adult rat and human cardiomyocytes cultured under high-lipid conditions, each treatment stimulated v-ATPase re-assembly, endosomal acidification, endosomal CD36 retention and prevented myocellular lipid accumulation. Additionally, these treatments preserved insulin-stimulated GLUT4 translocation and glucose uptake as well as contractile force. The present findings reveal v-ATPase functions as a key regulator of cardiomyocyte substrate preference and as a novel potential treatment approach for the diabetic heart.
topic vacuolar h<sup>+</sup>-atpase
lipid accumulation
insulin resistance
contractile function
diabetic heart
url https://www.mdpi.com/1422-0067/21/4/1520
work_keys_str_mv AT shujinwang augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction
AT liyenwong augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction
AT dietbertneumann augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction
AT yilinliu augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction
AT aominsun augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction
AT gudrunantoons augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction
AT agnieszkastrzelecka augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction
AT janfcglatz augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction
AT mirandanabben augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction
AT joostjfpluiken augmentingvacuolarhsupsupatpasefunctionpreventscardiomyocytesfromlipidoverloadinduceddysfunction
_version_ 1725043507800834048